Literature DB >> 32645942

Broad-Spectrum Cephalosporin-Resistant and/or Fluoroquinolone-Resistant Enterobacterales Associated with Canine and Feline Urogenital Infections.

Igor Loncaric1, Dusan Misic2,3, Michael P Szostak1, Frank Künzel4, Sabine Schäfer-Somi5, Joachim Spergser1.   

Abstract

The aim of the present study was to characterize Enterobacterales resistant to 3rd and 4th generation cephalosporins, carbapenems and/or fluoroquinolones, isolated from dogs and cats with urogenital infections. In total, 36 strains (Escherichia coli (n = 28), Klebsiella pneumoniae (n = 3), Serratia marcescens, Raoultella ornithinolytica, Proteus mirabilis, Citrobacter portucalensis and Enterobacter cloacae (each n = 1)) were included in the present study, 28 from Austria and 8 from Serbia. Isolates were characterized by a polyphasic approach including susceptibility pheno- and genotyping and microarray-based assays. Escherichia (E.) coli isolates were additionally characterized by two-locus (fumC and fimH) sequence phylotyping and multi-locus sequence typing (MLST) of selected isolates. MLST of carbapenem-resistant Enterobacter cloacae isolates was also performed. Among E. coli, the most dominant phylogenetic group was B1 (27.8%), followed by C, (16.6%), A and Clade II (5.5% each), B2 and F (2.77% each). The most predominant β-lactam resistance genes were blaTEM (70%) and blaCTX-M (38.8%), blaCMY (25%). blaNDM was detected in one carbapenem-resistant Enterobacter cloacae ST114. The most common ST among selected E. coli was 744 (10.7% isolates). The pandemic clones ST131 and ST648 carrying CTX-M-15 were also detected. Remaining STs belonged to 469, 1287, 1463 and 1642. E. coli clonotyping revealed 20 CH types. Based on the presence of certain virulence genes, three isolates were categorized as ExPEC/UPEC. The most prevalent virulence factors were fimH detected in 61%, iucD and iss both in 55%, iroN in 27.8%, papC in 13.8% and sat in 8.3% isolates.

Entities:  

Keywords:  AmpC; ESBL; Enterobacterales; ST114; ST131; ST648; carbapenem-resistant; cephalosporins; fluoroquinolones; infection; pandemic clone; urogenital system

Year:  2020        PMID: 32645942     DOI: 10.3390/antibiotics9070387

Source DB:  PubMed          Journal:  Antibiotics (Basel)        ISSN: 2079-6382


  5 in total

1.  Phylogeographical Landscape of Citrobacter portucalensis Carrying Clinically Relevant Resistomes.

Authors:  Fábio P Sellera; Miriam R Fernandes; Bruna Fuga; Herrison Fontana; Felipe Vásquez-Ponce; Daphne W Goldberg; Daniel F Monte; Larissa Rodrigues; Adriana R Cardenas-Arias; Ralf Lopes; Brenda Cardoso; Daniela G C Costa; Fernanda Esposito; Nilton Lincopan
Journal:  Microbiol Spectr       Date:  2022-03-31

2.  Editorial: Antimicrobial Resistance as a Global Public Health Problem: How Can We Address It?

Authors:  Luciene Andrade Da Rocha Minarini; Leonardo Neves de Andrade; Eliana De Gregorio; Filipa Grosso; Thierry Naas; Raffaele Zarrilli; Ilana L B C Camargo
Journal:  Front Public Health       Date:  2020-11-12

Review 3.  The Animal-foods-environment interface of Klebsiella pneumoniae in Germany: an observational study on pathogenicity, resistance development and the current situation.

Authors:  Gamal Wareth; Heinrich Neubauer
Journal:  Vet Res       Date:  2021-02-08       Impact factor: 3.683

4.  Whole-genome analyses of extended-spectrum or AmpC β-lactamase-producing Escherichia coli isolates from companion dogs in Japan.

Authors:  Mayo Yasugi; Shingo Hatoya; Daisuke Motooka; Yuki Matsumoto; Shunsuke Shimamura; Hiroyuki Tani; Masaru Furuya; Keiichiro Mie; Masami Miyake; Shota Nakamura; Terumasa Shimada
Journal:  PLoS One       Date:  2021-02-05       Impact factor: 3.240

5.  Alterations in chromosomal genes nfsA, nfsB, and ribE are associated with nitrofurantoin resistance in Escherichia coli from the United Kingdom.

Authors:  Yu Wan; Ewurabena Mills; Rhoda C Y Leung; Ana Vieira; Xiangyun Zhi; Nicholas J Croucher; Neil Woodford; Elita Jauneikaite; Matthew J Ellington; Shiranee Sriskandan
Journal:  Microb Genom       Date:  2021-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.